Is ImClone Out of the Woods?

   January 28, 2004    Comments Off on Is ImClone Out of the Woods?    Posted in: General Biotechnology

Is ImClone Out of the Woods?
If the FDA approves its Erbitux anticancer treatment, as S&P expects, the biotech’s volatile stock should be set for solid growth

  

Comments are closed.

Biotechblog